Haemonetics Corporation (HAE): Price and Financial Metrics

HAE POWR Grades

• Quality is the dimension where HAE ranks best; there it ranks ahead of 86.92% of US stocks.
• HAE's strongest trending metric is Growth; it's been moving down over the last 177 days.
• HAE ranks lowest in Momentum; there it ranks in the 10th percentile.

HAE Stock Summary

• HAE's one year PEG ratio, measuring expected growth in earnings next year relative to current common stock price is 125.51 -- higher than 79.34% of US-listed equities with positive expected earnings growth.
• HAE's went public 32.59 years ago, making it older than 84.3% of listed US stocks we're tracking.
• The volatility of HAEMONETICS CORP's share price is greater than that of only 6.06% US stocks with at least 200 days of trading history.
• If you're looking for stocks that are quantitatively similar to HAEMONETICS CORP, a group of peers worth examining would be CMCO, XGN, XRX, LXFR, and MTRN.
• HAE's SEC filings can be seen here. And to visit HAEMONETICS CORP's official web site, go to www.haemonetics.com.

HAE Valuation Summary

• HAE's price/earnings ratio is 32.8; this is 23.54% higher than that of the median Healthcare stock.
• Over the past 243 months, HAE's EV/EBIT ratio has gone up 13.3.

Below are key valuation metrics over time for HAE.

HAE Growth Metrics

The 3 year cash and equivalents growth rate now stands at 53.23%.
• Its 3 year net income to common stockholders growth rate is now at -21.16%.
• Its 5 year net income to common stockholders growth rate is now at 391.33%.

HAE's revenue has moved up $243,130,000 over the prior 70 months.

The table below shows HAE's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2022-12-31	1,129.246	261.497	95.759
2022-09-30	1,083.714	259.515	86.047
2022-06-30	1,026.126	215.936	67.706
2022-03-31	993.196	172.263	43.375
2021-12-31	953.223	105.76	22.593
2021-09-30	933.825	109.618	31.243

HAE's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• HAE has a Quality Grade of C, ranking ahead of 50% of graded US stocks.
• HAE's asset turnover comes in at 0.569 -- ranking 76th of 186 Medical Equipment stocks.
• CRY, CTSO, and CSII are the stocks whose asset turnover ratios are most correlated with HAE.

The table below shows HAE's key quality metrics over time.